Incidence of Breast Cancer in Markazi, Iran, Population-based Cancer Registry Results
Majid Taheri1, Javad Nazari2, Ali Arash Anoshirvani3, Reza Aghabozorgi3, Masoud Bahrami4, Amir Almasi Hashiani4, *
1 Medical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 School of Medicine, Arak University of Medical Sciences, Arak, Iran
3 Department of Hematology and Medical Oncology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
4 Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran
Breast Cancer (BC) is the most prevalent malignancy and a significant cause of cancer deaths in females all around the world. BC includes 16 percent of all cancers.
This study aimed at examining the epidemiology of BC in Markazi.
Materials and Methods:
This was an epidemiological study in which data resulted from the population-based cancer registry program in Markazi, Iran was used during the years 2010-2014. Data was recorded in Excel software and coded based on ICD-O and all duplicate reports were removed according to their unique codes. All cases out of Markazi were excluded from study and cases with code C-50 (all BC) were included in this study. SPSS ver.18 was used to analyze the data.
In this study, 1,254 new cases of BC in Markazi were included in the analysis. The highest cancer rate was reported in 2012 (319 cases). The highest crude rate of BC was reported in 2012 (45/100,000 people) and the lowest crude rate was reported in 2010 (26.2 /100,000 people). The Age-Specific Rates (ASR) of BC were 27, 37.3, 45.7, 39.8 and 31.5 per 100.000 people in 2010 to 2014, respectively. The highest ASR of BC was reported in 2012 (45.7/100,000 people) and the lowest ASR was reported in 2010 (27/100,000 people).
The results showed similar incidence rate of BC in Markazi as compared to other provinces in Iran. Efficient approaches should be considered for cancer registry systems especially BC.
Keywords: Age-specific rate, Breast cancer, Epidemiology, Markazi, Malignancy, ICD-O.
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
* Address correspondence to this author at the Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran;Tel: +98 9127067291; Email: email@example.com